Literature DB >> 4625157

Studies on the first component of complement (C1) and the inhibitor of C1 esterase in rheumatoid synovial fluids.

M M De Bracco, R M Stroud, C L Christian.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4625157      PMCID: PMC1553635     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  20 in total

1.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

2.  A stoichiometric assay for the fourth component of complement in whole human serum using EAC'la-gp and functionally pure human second component.

Authors:  S Ruddy; K F Austen
Journal:  J Immunol       Date:  1967-12       Impact factor: 5.422

3.  A simple method for producing antibody specific to a single selected diffusible antigen.

Authors:  R B Goudie; C H Horne; P C Wilkinson
Journal:  Lancet       Date:  1966-12-03       Impact factor: 79.321

4.  The relationship of the hemolytic activity of active C'1s to its TAMe esterase action: a new method of purification and assay.

Authors:  K Nagaki; R M Stroud
Journal:  J Immunol       Date:  1969-02       Impact factor: 5.422

5.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

6.  The stoichiometric measurement of the serum inhibition of the first component of complement by the inhibition of immune hemolysis.

Authors:  I Gigli; S Ruddy; K F Austen
Journal:  J Immunol       Date:  1968-06       Impact factor: 5.422

7.  Reactions of aggregated mercaptoethanol treated gamma globulin with rheumatoid factor--precipitin and complement fixation studies.

Authors:  N J Zvaifler; P Schur
Journal:  Arthritis Rheum       Date:  1968-08

8.  Clinical studies of hemolytic complement and the 11S component.

Authors:  L B Hanauer; C L Christian
Journal:  Am J Med       Date:  1967-06       Impact factor: 4.965

9.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

10.  Breakdown products of C 3 in human synovial fluids.

Authors:  N J Zvaifler
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

View more
  4 in total

1.  Determination of C1s-C1 inhibitor complexes in plasma by means of an enzyme linked immunosorbent assay.

Authors:  T Nilsson; O Bäck
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

2.  Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin.

Authors:  P C Harpel; N R Cooper
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

3.  Persistent glomerulonephritis following the haemolytic-uremic syndrome. Immunopathological and morphological studies.

Authors:  P M Cossio; R P Laguens; D J Pantin; M M de Bracco; F Molinas; L E Voyer; R M Arana
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

4.  C1 inactivator-C1s complexes in inflammatory joint disease.

Authors:  R D Inman; P C Harpel
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.